Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics. Philadelphia: Lea and Febiger; 1984. p. 257–85.
2. US FDA. Guidance for industry: general clinical pharmacology considerations for pediatric studies for drugs and biological products. US FDA; 2014.
3. Salerno SN, Burckart GJ, Huang SM, Gonzalez D. Pediatric drug–drug interaction studies: barriers and opportunities. Clin Pharmacol Ther. 2019;105:1067–70.
4. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157–67.
5. Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet. 2002;41:959–98.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献